Ceribell (CBLL) director Parvizi granted 7,838 RSUs and updates trust holdings
Rhea-AI Filing Summary
Parvizi Josef reported acquisition or exercise transactions in this Form 4 filing.
Ceribell, Inc. director Josef Parvizi reported an equity award and updated share holdings. He received a grant of 7,838 restricted stock units (RSUs) of common stock at a price of $0.00 per share, increasing his directly held RSUs to 23,284. Footnotes explain that 15,446 of these RSUs were previously reported as indirectly held through the Josef Parvizi Trust but are now held directly.
In addition to the direct RSUs, the filing lists indirect holdings of common stock through three trusts as of the transaction date: 707,206 shares by the Josef Parvizi Trust, 907,911 shares by the Innovation ACP Trust, and 369,088 shares by the ACP 2021 Trust. Parvizi is trustee or co‑trustee of these trusts and may be deemed to have beneficial ownership, but he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Routine RSU grant and ownership reclassification with substantial trust holdings disclosed.
The filing shows Josef Parvizi receiving 7,838 RSUs of Ceribell, Inc. common stock at $0.00 per share, bringing his directly held RSUs to 23,284. This is coded as an A‑type grant, a standard form of stock-based compensation.
Footnotes clarify that 15,446 RSUs previously attributed to the Josef Parvizi Trust are now reported as held directly, while large indirect positions remain in three trusts with 707,206, 907,911, and 369,088 shares. Parvizi is trustee or co‑trustee and may be deemed to share beneficial ownership, but he disclaims beneficial ownership beyond his pecuniary interest.
Overall, this appears to be a routine compensation and reporting update rather than a market transaction. There are no open-market buys or sells, and no derivative exercises or expirations are listed in the provided excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,838 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents restricted stock units ("RSUs"). Includes 23,284 RSUs held directly by the Reporting Person. 15,446 RSUs were previously reported as being held indirectly through the Josef Parvizi Trust. The shares reported as indirectly owned by the Josef Parvizi Trust no longer include 15,446 RSUs. Such RSUs were previously reported as being held through the trust but are held directly by the Reporting Person. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.